Genomics England

Genomics England is a British company set up and owned by the United Kingdom Department of Health and Social Care to run the 100,000 Genomes Project. The project aimed in 2014 to sequence 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. An infectious disease strand is being led by Public Health England.

Genomics England
Formation5 July 2013
HeadquartersOne Canada Square, Canary Wharf, London, England
Parent organization
Department of Health and Social Care
Websitewww.genomicsengland.co.uk

In the summer of 2019, Chris Wigley was appointed CEO of Genomics England, starting in October 2019. Wigley is a former McKinsey executive known for applying machine learning and artificial intelligence technology.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.